| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3187916 | Annales de Dermatologie et de Vénéréologie | 2011 | 5 Pages |
Abstract
Neutrophilic panniculitis is uncommon among patients treated with tyrosine kinase inhibitors and has only been described in patients treated for chronic myeloid leukaemia. We discuss the potential causative role of imatinib mesilate and dasatinib in onset of the disease, as well as differential diagnosis of neutrophilic panniculitis, which resembles subcutaneous Sweet's syndrome.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
A. de Masson, S. Bouvresse, T. Clérici, E. Mahé, P. Saïag,